Dose and Efficacy of Bevacizumab in Recurrent High-Grade Gliomas: A Retrospective Study.

Cancer Manag Res · 2024 · PMC11578801 · PMID 39575164

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

While the OS was longer in the BEV group compared to the non-BEV group, the observed difference did not reach statistical significance, indicating a limited impact of BEV on OS.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.